[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

January 2020 | 103 pages | ID: G56D1BFFFF8EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

MARKET OVERVIEW

The global 23-Valent Pneumococcal Polysaccharide Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3549.3 million by 2025, from USD 2117.7 million in 2019.
The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

MARKET SEGMENTATION

23-Valent Pneumococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, 23-Valent Pneumococcal Polysaccharide Vaccine market has been segmented into Single Dose Vial, Pre-filled Syringe, etc.
By Application, 23-Valent Pneumococcal Polysaccharide Vaccine has been segmented into For Children (2-10), For Person (10-64), For The Old (?65), etc.

REGIONS AND COUNTRIES LEVEL ANALYSIS

Regional analysis is another highly comprehensive part of the research and analysis study of the global 23-Valent Pneumococcal Polysaccharide Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level 23-Valent Pneumococcal Polysaccharide Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global 23-Valent Pneumococcal Polysaccharide Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the 23-Valent Pneumococcal Polysaccharide Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional 23-Valent Pneumococcal Polysaccharide Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
23-Valent Pneumococcal Polysaccharide Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, 23-Valent Pneumococcal Polysaccharide Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the 23-Valent Pneumococcal Polysaccharide Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in 23-Valent Pneumococcal Polysaccharide Vaccine are: MSD, Sanofipasteur, CDIBP, etc. Among other players domestic and global, 23-Valent Pneumococcal Polysaccharide Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe 23-Valent Pneumococcal Polysaccharide Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of 23-Valent Pneumococcal Polysaccharide Vaccine in 2018 and 2019.
Chapter 3, the 23-Valent Pneumococcal Polysaccharide Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-Valent Pneumococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, 23-Valent Pneumococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe 23-Valent Pneumococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 23-Valent Pneumococcal Polysaccharide Vaccine Introduction
1.2 Market Analysis by Type
  1.2.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type: 2015 VS 2019 VS 2025
  1.2.2 Single Dose Vial
  1.2.3 Pre-filled Syringe
1.3 Market Analysis by Application
  1.3.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application: 2015 VS 2019 VS 2025
  1.3.2 For Children (2-10)
  1.3.3 For Person (10-64)
  1.3.4 For The Old (?65)
1.4 Overview of Global 23-Valent Pneumococcal Polysaccharide Vaccine Market
  1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Status and Outlook (2015-2025)
  1.4.2 North America (United States, Canada and Mexico)
  1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
  1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 MSD
  2.1.1 MSD Details
  2.1.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
  2.1.3 MSD SWOT Analysis
  2.1.4 MSD Product and Services
  2.1.5 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofipasteur
  2.2.1 Sanofipasteur Details
  2.2.2 Sanofipasteur Major Business and Total Revenue (Financial Highlights) Analysis
  2.2.3 Sanofipasteur SWOT Analysis
  2.2.4 Sanofipasteur Product and Services
  2.2.5 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CDIBP
  2.3.1 CDIBP Details
  2.3.2 CDIBP Major Business and Total Revenue (Financial Highlights) Analysis
  2.3.3 CDIBP SWOT Analysis
  2.3.4 CDIBP Product and Services
  2.3.5 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 SALES, REVENUE AND MARKET SHARE BY MANUFACTURER

3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
  3.3.1 Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2019
  3.3.2 Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend

4 GLOBAL MARKET ANALYSIS BY REGIONS

4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
  4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2015-2020)
  4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.5 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)

5 NORTH AMERICA BY COUNTRY

5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
  5.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
  5.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)

6 EUROPE BY COUNTRY

6.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
  6.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
  6.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.3 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)

7 ASIA-PACIFIC BY REGIONS

7.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
  7.1.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2015-2020)
  7.1.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.5 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)

8 SOUTH AMERICA BY COUNTRY

8.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
  8.1.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
  8.1.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)

9 MIDDLE EAST & AFRICA BY COUNTRIES

9.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
  9.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
  9.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)

10 MARKET SEGMENT BY TYPE

10.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2015-2020)

11 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SEGMENT BY APPLICATION

11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)

12 MARKET FORECAST

12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Regions (2021-2025)
  12.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
  12.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
  12.2.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
  12.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
  12.2.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2021-2025)
  12.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2025)
  12.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2021-2025)
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2021-2025)
  12.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2025)
  12.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2021-2025)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

LIST OF TABLES

Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. MSD Basic Information, Manufacturing Base and Competitors
Table 8. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Major Business
Table 9. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. MSD SWOT Analysis
Table 11. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 12. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 14. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Major Business
Table 15. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Sanofipasteur SWOT Analysis
Table 17. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 18. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. CDIBP Basic Information, Manufacturing Base and Competitors
Table 20. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Major Business
Table 21. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. CDIBP SWOT Analysis
Table 23. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 24. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2018-2019) (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions (2015-2020) (K Dose)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2015-2020)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 30. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 31. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 32. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Table 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions (2015-2020) (K Dose)
Table 38. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 40. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 41. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 42. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 45. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2015-2020) (K Dose)
Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2015-2020)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020) (USD Million)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2015-2020) (K Dose)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2015-2020)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions (2021-2025) (K Dose)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Regions (2021-2025)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2025) (K Dose)
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2021-2025)
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2025)
Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List

LIST OF FIGURES

Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Picture
Figure 2. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2019
Figure 3. Single Dose Vial Picture
Figure 4. Pre-filled Syringe Picture
Figure 5. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2018
Figure 6. For Children (2-10) Picture
Figure 7. For Person (10-64) Picture
Figure 8. For The Old (?65) Picture
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2018
Figure 46. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 49. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 50. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 55. UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 56. France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 57. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 58. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 59. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions 2019
Figure 62. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 63. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 64. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 65. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 66. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 67. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2019
Figure 69. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 71. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 72. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 77. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 78. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 79. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2025) (K Dose)
Figure 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 83. Europe Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 84. Asia-Pacific Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 85. South America Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 86. Middle East & Africa Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel


More Publications